European committee takes a second look at Alzheimer's drug and now says it should be approved - Peer2Peer

European committee takes a second look at Alzheimer's drug and now says it should be approved

Nov 14, 2024

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug

https://abcnews.go.com/Business/wireStory/european-committee-takes-alzheimers-drug-now-approved-115871668

Respond, make new discussions, see other discussions and customize your news...
Log in.

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Terms of Service